UNSPSC 51263109: Bevantolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C20H27NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 34ZXW6ZV21, chemically known as 2-propanol, 1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)- but generally known as bevantolol, which bears US NIH Compound Identifier 2372. Bevantolol most often comes in base, hydrochloride, and metabolite forms.

UNSPSC 51263109 Bevantolol, a Commodity code, does not align with the state and local contract opportunities recently tagged under it. The two recent opportunities on record—one soliciting naloxone and drug deactivation systems from Seminole County, Florida, and another issuing a Request for Information from the Texas Health and Human Services Commission regarding direct-to-manufacturer prescription programs—fall outside the scope of bevantolol, a specific beta-blocker pharmaceutical. The code shows little relevant recent activity in state and local procurement channels.

The mismatch between the code's nominal product scope and the actual opportunities filed under it suggests either a tagging error in the underlying procurement records or a broader categorization issue in how the state and local market classifies pharmaceutical procurement. Business development professionals monitoring this code should verify whether opportunities in beta-blocker pharmaceuticals or naloxone-related products are being posted under alternate UNSPSC classifications before concluding that demand under 51263109 is inactive.